Challenge
A beverage manufacturer’s new sports drink combined technical development with evidence requirements for a nutraceutical ingredient. Missed milestones, differing expectations, and unsuitable overseas study data had delayed the intended launch.
Response
PMO Partners applied regulated-development experience to clarify study deliverables, improve communication with research partners, and support a replacement CRO arrangement. A revised timeline, contingency plan, defined responsibilities, and shared document repository connected functional teams and external experts.
Outcome at publication
The company organized its evidence and prepared for a Generally Recognized as Safe submission using a more realistic development plan. The source states that FDA acknowledgment was still awaited. This case therefore describes improved readiness and coordination, not a completed FDA approval or an established launch outcome.
An edited client story. Outcomes and figures describe the reported engagement, rather than a promise of results for another organization.